Numinus Wellness Inc. (OTCQX:NUMIF), a company focused on the development and delivery of innovative mental health care through evidence-based psychedelic-assisted therapies, announced that its shareholders approved the issuance of common shares in connection with the proposed acquisition of Novamind Inc. (OTCQB:NVMDF).
Novamind shareholders have also voted to approve the previously proposed acquisition of Numinus in an all-share transaction, pursuant to a plan of arrangement, at a separate meeting of Novamind shareholders. The transaction required approval by a simple majority of the votes and by not less than two-thirds of the shareholders’ votes entitled to vote at the special meeting that took place in the first days of May. A total of 28,403,240 Novamind shares were voted, representing approximately 57.0% of the issued and outstanding shares as of May 2, with 98.5% voting in favor.
